1. Advances in the physics studies for the JT-60SA tokamak exploitation and research plan. (24th October 2019) Authors: Giruzzi, G; Yoshida, M; Aiba, N; Artaud, J F; Ayllon-Guerola, J; Beeke, O; Bierwage, A; Bolzonella, T; Bonotto, M; Boulbe, C; Chernyshova, M; Coda, S; Coelho, R; Corona, D; Cruz, N; Davis, S; Day, C; De Tommasi, G; Dibon, M; Douai, D Journal: Plasma physics and controlled fusion Issue: Volume 62:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Issue 11 (November 1994) Authors: Minami, T; Tojo, H; Shinomura, Y; Matsuzawa, Y; Okamoto, M Journal: Gut Issue: Volume 35:Issue 11(1994) Page Start: 1593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Plasma physics and control studies planned in JT-60SA for ITER and DEMO operations and risk mitigation. (1st May 2022) Authors: Yoshida, M; Giruzzi, G; Aiba, N; Artaud, J F; Ayllon-Guerola, J; Balbinot, L; Beeke, O; Belonohy, E; Bettini, P; Bin, W; Bierwage, A; Bolzonella, T; Bonotto, M; Boulbe, C; Buermans, J; Chernyshova, M; Coda, S; Coelho, R; Davis, S; Day, C Journal: Plasma physics and controlled fusion Issue: Volume 64:Number 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Issue 7 (July 1992) Authors: Minami, T; Tojo, H; Shinomura, Y; Tarui, S; Okamoto, M Journal: Gut Issue: Volume 33:Issue 7(1992) Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗